Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 381

Diabetics at Increased Risk of Hearing Loss

Diabetics have twice the risk of developing hearing loss as are nondiabetics.

Catherine C. Cowie, PhD, director, diabetes epidemiology program, National Institute of Diabetes and Digestive and Kidney Diseases, reported data in 5,140 individuals aged 20 to 69 years who underwent audiometric testing from 1999 through 2004 as part of the National Health and Nutrition Examination Survey (NHANES).

"The pathologic changes that accompany diabetes could plausibly affect the vasculature or the neural system of the inner ear, resulting in sensorineural hearing impairment," Dr. Cowie explained in a presentation..

In the NHANES trial, pure tone thresholds over lower frequency were obtained for each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz using a calibrated audiometer in a soundproof booth. A pure tone average exceeding 25 decibels over a given frequency range in both ears indicated hearing impairment.

After adjusting for age, 31.6% of self-reported diabetics had hearing impairment at the lower frequency range versus 14.5% of the nondiabetic subjects. The figures were 56.8% and 35.8% for the two groups, respectively, at the higher frequency range.

The analysis also revealed that diabetics had higher age-adjusted mean pure tone thresholds at all frequencies than nondiabetics.

Dr. Cowie pointed out that the mechanism for hearing loss in diabetics has not been clarified but may be vascular or neurological.

"The high prevalence of hearing impairment among people with diabetes in our nationally representative sample suggests that screening diabetic patients for hearing impairment is appropriate," she said.

[Presentation title: Diabetes and Hearing Impairment: Audiometric Evidence From the National Health and Nutrition Examination Survey, 1999-2004. Abstract 991-P]


Dr. Philip A. Wood has written a book for healthcare professionals and students of medicine, nursing, pharmacy, and graduate studies, as well lay people interested in understanding the influences of genetics, nutrition, activity level and drugs on diseases associated with excess fat such as obesity, insulin resistance, metabolic syndrome and type 2 diabetes. The book is composed of short, readable chapters with helpful figures to further explain the mechanisms discussed. For further information please click here.



Bookmark and Share | Print | Category | Home

This article originally posted 11 September, 2007 and appeared in  Issue 381

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?